Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Union Bio-Technology is a China-based in vitro diagnostics and medical test manufacturer focused on rapid self-test and point-of-care style diagnostic products. Publicly available information indicates the company develops, produces, and sells biological reagents and diagnostic test strips, with notable commercial products in fertility and women's health testing such as early pregnancy, ovulation, and vaginitis tests. The company appears to market products under the "Sisters" brand and emphasizes export-oriented manufacturing. Available evidence suggests it operates as a commercial diagnostics manufacturer rather than a therapeutic drug developer, so traditional biotech pipeline, target, and clinical-stage fields are limited. Its business profile is most consistent with an active private healthcare company serving consumer and diagnostic markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Union Bio-Technology.